Contact phone: 425.889.9192

OVP invests in early stage companies in cleantech, digital biology and information technology. OVP partners take a board seat with every investment and are highly active in guiding each company. Our initial investment is typically $1M – $5M, growing to $8M – $15 million over the life of the deal. Out of more than 103 investments over 30 years, OVP has produced 25 IPOs and 35 acquisitions.

Current Portfolio

Accelerator Corp.

Seattle, WA Investment in and management of emerging biotech opportunities
Visit Website

Adapx

Seattle, WA Products for natural, mobile field data collection
Visit Website

Collaborative Software

Portland, OR Enterprise IT with an open source development approach
Visit Website

Cradlepoint Technology

Boise, ID Equipment and software for cellular and wireless communications
Visit Website

Datasphere Technologies

Bellevue, WA Web technology and hyperlocal sales solutions
Visit Website

EnerG2

Seattle, WA Addresses commercial and technical challenges of energy storage
Visit Website

Fate Therapeutics

San Diego, CA Guiding Cells to Improve Life
Visit Website

GenoLogics

Victoria, BC Informatics platform for Proteomics & Genomics
Visit Website

NanoString Technologies

Seattle, WA Bar coding systems for single molecules
Visit Website

Novomer

Boston, MA CO2 and CO catalysis technology
Visit Website

OncoFactor

Seattle, WA Antibody drugs against new biologic targets in cancer
Visit Website

RedSeal

Santa Clara, CA Security assurance software
Visit Website

Symform

Seattle, WA Decentralized cloud computing systems
Visit Website

Talyst

Bellevue, WA Pharmacy automation in hospitals and long-term care facilities
Visit Website

Tigo Energy

Los Gatos, CA Hardware and software solutions making solar energy installations more efficient
Visit Website

Verdezyne

Carlsbad, CA Engineering metabolic pathways for converting renewable feedstocks into industrial chem
Visit Website